BMJ Open Diabetes Res Care 10(6):e002995 Jermendy G, Kiss Z, Rokszin G, Abonyi-Tth Z, Lengyel C, Kempler P et al (2022) Changing patterns of antihyperglycaemic treatment among patients with type 2 diabetes in Hungary between 2015 and 2020-nationwide data from a register-based analysis
Body composition analysis Fat and lean tissue mass were measured via nuclear magnetic resonance technology (EchoMRI)
Trending topics were health ( n = 117 posts), dogs ( n = 115 posts), and clinical medicine ( n = 113 posts), while the most frequently mentioned keywords in the dataset were medication, dogs, and home. The majority of keywords in these posts had a positive sentiment, but it was not possible to draw any firm conclusions on discussions around larger dogs and issues around pilling
Medical weight loss works best when treatment is based on the individual patient rather than a standard plan
Replenza versus Evolv GLP-1 Evolv GLP-1 takes a different approach to GLP-1 support, focusing on natural GLP-1 enhancement rather than nutrient replenishment
Metformin is the first-line treatment for type 2 diabetes and works primarily by reducing hepatic glucose production and improving insulin sensitivity